New Approved Cancer Drugs Failing Miserably. By Dr. Mercola. According to the National Cancer Institute, in 2. They anticipate the number of newly diagnosed cases will rise to over 2. These statistical trends are used to measure success of efforts to prevent or treat cancers. Mainstream medicine relies on pharmaceutical companies to develop toxins that may kill cancer cells and extend the life of those suffering from the disease. Unfortunately, cancer cells develop in unique and highly variable processes, creating cell overgrowths that do not respond to just one or two types of medication. Pressured by patient advocates who want earlier access to novel medications, the U. S. Food and Drug Administration (FDA) began approving cancer drugs without requisite proof they either extend the life of the patient or kill cancer cells. Meanwhile, emerging evidence indicates diets high in healthy fats, low in net carbs and moderate in protein are ideal to reduce insulin levels, balance leptin and ghrelin hormones, reduce obesity and even help prevent and treat cancers, as it normalizes the underlying metabolic dysfunction. In other words, this type of nutritional plan improves your overall health, increases your energy level and improves weight loss efforts with a greater proportion of the fat removed from the abdominal cavity, also called visceral fat. Changing your diet is often financially neutral, while cancer drugs may cost upwards of $1. Many Drugs Don't Live Up to the Promise. Pass the mustard and those health benefits please. Wednesday, January 05, 2011 by: Christine Roberts Tags: mustard, health food, health news.In a rush to bring medications to market, many of them are not helping patients and some are being removed. Earlier access to cancer drugs may have given patients renewed hope, but have also increased Big Pharma's financial gains without a parallel improvement in patient results. Overall successes in the past decade have barely changed. According to a study published in the Journal of the American Medical Association (JAMA), 7. FDA between 2. 00. Two- thirds of the drugs approved between 2. Another study reported in JAMA evaluated 1. Dr. Richard Schilsky, senior vice president and chief medical officer at the American Society of Clinical Oncology, commented on the current drug therapies available to patients, saying: 8. You begin to question what is the real value of a therapy, when the benefit is small, the toxicity may be similar to a previous drug and the cost is much higher. This has meant some drugs found to extend the life of patients with liver cancer had no effect on Medicare patients once the drug was approved. Caffeine is a central nervous system (CNS) stimulant of the methylxanthine class. It is the world's most widely consumed psychoactive drug. Unlike many other. In 1933, an American researcher discovered that when taken by humans, DNP dramatically speeds up the metabolism leading to rapid weight loss. It was subsequently.
Four years after the start of the study, only five medications demonstrated any evidence they helped survival rates for patients. Lowering approval standards doesn't benefit patients or doctors, but does fund pharmaceutical companies bent on developing new products for a growing market. As if these standards were not low enough, President Trump has declared his intention to cut FDA regulations even further to speed the drug approval processes. Fast approvals in the past have also resulted in medications withdrawn from the market as they didn't help patients, and in some instances caused harm. The slow pace of progress in cancer treatments using drugs has triggered the American Society of Clinical Oncology to lower standards for medications, setting the goal to extend life or control the growth of tumors by a mere 2. However, in a study published in JAMA, researchers found that only one of every five cancer drugs in use approved between 2. Operating under stressful conditions, most patients mistakenly believe the FDA only approves extremely effective drugs and 2. Even physicians overestimate the benefits of the drugs and underestimate the risks to the patients. The drug Avastin is one example of a cancer medication approved without evidence of survival benefits that was later withdrawn, as the side effects appeared to outweigh the lack of established benefits. Studies found that not only did it not help people live longer, side effects were life- threatening, including heart attack, bleeding and high blood pressure. Shooting for the Moon Isn't Working Either. In 2. 01. 6, Dr. Patrick Soon- Shiong launched a bold collaboration of physicians, companies, researchers, academics and governmental agencies with the mission to eradicate cancer. He called it Moonshot 2. Their goal was to forever change the face of medicine. Supremely confident in his ability to make good on his promise, Soon- Shiong has even met with President Trump twice in the three months since the election, reportedly pitching the idea of a senior health care role in the administration. This role in a governmental agency would represent a distinct conflict of interest between administering health care policy and Soon- Shiong's private business concerns of promoting new cancer diagnostic tools. To date, there has been little progress at the core of the initiative. The essence of the moonshot design is to aggressively promote a yet unproven diagnostic tool, called GPS Cancer, which reportedly analyzes tumors and recommends a course of treatment involving immunotherapy. In published statements Soon- Shiong mentions collaborators, including pharmaceutical companies Pfizer, Merck and Johns Hopkins. However each of those companies deny knowledge of their involvement. In their social media campaigns the moonshot team claims they will have developed a vaccine that could treat all cancer types at every stage by 2. Dr. Eric Topol, geneticist who directs the Scripps Translational Science Institute, commented on Soon- Shiong's claim for a universal treatment. And if there is more, it sure isn't published. The idea that one vaccine or drug is able to prevent or cure this disease is not feasible. Prevention begins by denying cancer cells the very nutrition they need to develop and grow. That's where nutritional ketosis comes in. However, the protective power of vitamin D is not to be overlooked either. Raising your vitamin D serum levels to 4. Vitamin D influences virtually every cell in your body, and is crucial to reduce your risk of cancer. Your organs convert vitamin D in into calcitriol, which is the hormonal or activated version of vitamin D. Your organs then use it to repair damage, including that from cancer cells. Vitamin D also triggers apoptosis (cell death) in cancer cells. According to Cedric Garland, who holds a doctor of public health and who has published numerous studies on vitamin D, in nearly all forms of breast cancer, vitamin D affects the structure of epithelial cells. These cells, held together by a glue- like substance called E- cadherin made mostly of vitamin D and calcium, provide structure to the cell. Without adequate vitamin D, that structure comes apart and cells do what they are programmed to do in order to survive — they go forth and multiply. When cell proliferation gets out of control, it may result in cancer. If you have cancer in progress, the addition of vitamin D can help slow down cancer cells by replenishing E- cadherin. Once cancer growth has slowed, your immune system may be able to address the remaining cell growth more effectively. Cancer Cells and Genes. Chromosomal damage that triggers the proliferation of cells is likely a marker of cancer growth and not the actual cause of the disease. In other words, evidence is demonstrating that something other than gene mutation is at the root of cancer cell growth. The National Atlas Genome project,2. The primary consideration in the health of your cell mitochondria is glucose metabolism. This theory was originally proposed by Dr. Otto Warburg in the 1. Today, several scientists have continued the work on this metabolic theory, including Dr. Gary Fettke and molecular biologist James Watson. Science writer Travis Christofferson details some of this important work in his book . Today, Watson believes targeting cellular metabolism holds more promise than a gene- centered approach to cancer, which has not produced results researchers had hoped it would. Researchers at top cancer hospitals who are pushing for research into this metabolic theory of cancer development and subsequent treatment protocols include Dr. Craig Thompson, chief executive at Memorial Sloan Kettering Cancer Center and Peter Pedersen, biological chemistry and oncology professor at Johns Hopkins University, among others. The metabolic theory of cancer has demonstrated positive results in treatment. Ketogenic Diet May Reduce Cancer Cell Growth. In this short video you'll hear from a patient given three months to live from metastatic cancer, who subsequently began a ketogenic diet. The video was shot one year after the prognosis was issued. Essentially, Warburg discovered that in the presence of oxygen, cancer cells produce energy anaerobically, in the cytoplasm, generating lactic acid as a toxic byproduct. Energy production in the mitochondria is far more efficient but unavailable to cancer cells. This meant cancer cells are dependent on glucose to produce energy for cell repair and replication. A ketogenic diet drastically reduces net carbohydrate intake, causing your body to burn fat as its primary fuel, thereby producing ketones, which the mitochondria in your cells can readily use for energy. Ketones burn very efficiently and produce lower amounts of free radicals compared to other fuels. This diet has been successfully used for years to control seizure activity in children. While the typical Western diet is 5. However, if your aim is cancer prevention and improved health, 7. By eliminating the energy supply to cancer cells, research is finding the diet is a strong addition to cancer treatment,3. A ketogenic diet also reduces the anabolic hormone, insulin, which sparks the growth of cells, including cancer cells. When insulin levels are low it may slow the growth of cancers. Even in a pilot trial of 1. Ketogenic Diet Offers More Advantages A ketogenic diet offers not only advantages in the treatment of cancer, but also in the prevention of the development of abnormal cell proliferation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |